FibroBiologics Wins European Patent for Cancer Fibroblasts
The European Patent Office granted patent EP 4454709 covering fibroblast-based delivery of tumour-inhibiting agents.
Houston Diseases News
In Houston, diseases news means medical conditions, treatment breakthroughs, public health alerts and diagnostic advances. This page covers the public health impact of these conditions and the science behind them.
Alzheimer’s
Live Poll
Do you believe new research methods are successfully accelerating the development of treatments for neurodegenerative diseases?
Coya Therapeutics Refines ALS Trial Stratification
The company introduced a new method to categorize trial participants by protein levels at the 2026 Annual NEALS Meeting.
Diabetes
Live Poll
Would you prefer a one-time treatment over recurring injections for chronic health management?
FibroBiologics Filed Patent for Cell-Based GLP-1 Therapy
The Houston-based firm has proposed a new technology designed to produce peptides inside the human body.
Asthma
Meteorologist Daji Aswad Relocated Temporarily to Roanoke
The KPRC 2 meteorologist has moved to a sister station in Virginia for a short-term assignment.
Cancer
MD Anderson Plans $3.4 Billion Houston Expansion
The Houston cancer center will add a 25-story tower and a radiation oncology building in the Texas Medical Center.
Stroke
Houston Hospital Increases Use of TwitchView Monitor
A study presented at the ANESTHESIOLOGY 2026 meeting shows improved clinical adoption of neuromuscular monitoring in Houston.
More in Diseases
Regular subjects here include outbreaks, clinical trial results, treatment approvals, risk factor studies and awareness campaigns. Coverage runs across the city and the communities around it. Urban density and the local climate play a role in how public health alerts develop and spread. Tracking the availability of new treatments and their accessibility remains a primary focus of this reporting.